Assessment of Clinical Risk Factors for Symptomatic Venous Thromboembolism in Common Cancers: A VERITY Registry Study
Shankaranarayana Paneesha(Warwick Hospital), Peter Rose(Academy of Nutrition and Dietetics), Roopen Arya(King's College Hospital NHS Foundation Trust), Anthea Nieland(Northampton General Hospital NHS Trust), Timothy Farren(Barts Health NHS Trust), Sue Bacon(Scarborough General Hospital), Aidan McManus(University of Surrey), Nicholas Scriven(Calderdale Royal Hospital), Denise O’Shaughnessy(Department of Health and Social Care), Tim Nokes(Derriford Hospital)
Cited by 0
Related Papers
Hydrogen Sulfide and Cell Signaling
|The Annual Review of Pharmacology and Toxicology|2011|1.3k
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|867
Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents
|Natural Product Reports|2005|469
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
|Signal Transduction and Targeted Therapy|2023|457
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias
|British Journal of Haematology|2003|381